Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia
Background. Acute limb ischemia (ALI) is associated with significant morbidity and mortality. Novel anticoagulants reduce adverse events among patients with peripheral artery disease, though the potential effect of these therapies is unclear in patients with ALI. The present study thus sought to eva...
Saved in:
| Main Authors: | Scott Freeman, Piper Williams, Anna E. Barón, Mary E. Plomondon, Stephen W. Waldo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Vascular Medicine |
| Online Access: | http://dx.doi.org/10.1155/2022/3786815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia
by: Sreekanth Vemulapalli, MD, et al.
Published: (2025-08-01) -
Association of Lipoprotein(a) With Major Adverse Limb Events and All‐Cause Mortality Following Revascularization for Chronic Limb‐Threatening Ischemia: A Substudy of the BEST‐CLI Trial
by: Alexander E. Sullivan, et al.
Published: (2025-06-01) -
Association of the Naples Prognostic Score with Long-Term Adverse Events in Chronic Limb-Threatening Ischemia After Below-the-Knee Endovascular Revascularization
by: Emir Dervis, et al.
Published: (2024-11-01) -
Sexually Transmitted Ischemia, the Other STI: A Case of Gonococcal Endocarditis With Acute Limb Ischemia
by: Molly Whittaker, et al.
Published: (2024-07-01) -
Treatment results in patients with acute limb ischemia
by: V. A. Gubka, et al.
Published: (2018-08-01)